ImageneBio grants CFO 56K options, 104K RSUs
ImageneBio, Inc. reported equity compensation awards to its Chief Financial Officer, Yanina Grant-Huerta.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
ImageneBio, Inc. reported equity compensation awards to its Chief Financial Officer, Yanina Grant-Huerta. On August 14, 2026 she received a grant of 56,000 stock options with an exercise price of $5.84 per share, expiring on August 13, 2036. She also received a total of 104,000 restricted stock units, represented by two grants of 65,000 and 39,000 shares of common stock underlying RSUs. Footnotes state these updated awards replace a previously described but not yet granted package, and that 25% of both the RSUs and options vest on July 20, 2027 with the remainder vesting in equal periodic installments thereafter, subject to continued service.
Insider Trade Summary
Grant/Award: 160,000 shares
Grant/Award
3 txns
Insider
Grant-Huerta Yanina
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) F1, F3 | 56,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1, F2 | 65,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1, F2 | 39,000 | $0.00 | $0.00 |
Holdings After Transaction:
Employee Stock Option (right to buy) — 56,000 contracts (Direct);
Common Stock — 104,000 shares (Direct)
Footnotes (3)
- F1. On July 23, 2026, the Issuer filed a Current Report on Form 8-K reporting that the Reporting Person was entitled to receive pursuant to her employment offer letter 65,000 restricted stock units ("RSUs") and 95,000 stock options. It was subsequently determined that in lieu of the foregoing grants which had not yet been made, the Reporting Person would receive 104,000 restricted stock units in the aggregate and 56,000 options (the "Options"). These updated awards were granted on August 14, 2026 and are reported herein.
- F2. Represents the number of shares of the Issuer's Common Stock underlying RSUs. Each RSU represents the contingent right to receive one share of Common Stock upon settlement. 25% of RSUs will vest and settle into Common Stock on July 20, 2027, and the remaining RSUs will vest in a series of 12 equal quarterly installments thereafter, subject to the Reporting Person's continuous service with the Issuer through each such vesting date.
- F3. The Options vest over four years, with 25% of the shares vesting on July 20, 2027, and the remaining shares vesting in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer through each such vesting date.
Key Figures
Stock options granted: 56,000 shares
Option exercise price: $5.84 per share
Option expiration date: August 13, 2036
+4 more
7 metrics
Stock options granted
56,000 shares
Employee Stock Option grant to CFO on August 14, 2026
Option exercise price
$5.84 per share
Exercise price of 56,000 stock options granted to CFO
Option expiration date
August 13, 2036
Expiration date of CFO’s 56,000 stock options
RSUs granted (total)
104,000 RSUs
Aggregate RSUs granted in lieu of earlier-described awards
First vesting date (RSUs and options)
July 20, 2027
25% of RSUs and 25% of options vest on this date
RSU vesting installments
12 quarterly installments
Remaining RSUs vest in 12 equal quarterly installments after July 20, 2027
Option vesting installments
36 monthly installments
Remaining options vest in 36 successive equal monthly installments after July 20, 2027
Key Terms
restricted stock units, contingent right, vest, exercise price, +1 more
5 terms
restricted stock units financial
"Represents the number of shares of the Issuer's Common Stock underlying RSUs."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"Each RSU represents the contingent right to receive one share of Common Stock"
vest financial
"25% of RSUs will vest and settle into Common Stock on July 20, 2027"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
exercise price financial
"Employee Stock Option (right to buy) with a conversion or exercise price"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
installments financial
"remaining shares vesting in a series of 36 successive equal monthly installments"
Installments are a series of scheduled partial payments that together cover a larger amount owed or due, like paying for a purchase or loan in weekly or monthly pieces rather than all at once. For investors, installments matter because they change when cash moves between parties, affect a company’s or counterparty’s short-term cash flow and risk of missed payments, and can influence valuation or perceived financial stability much like spreading the cost of a car over monthly payments.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did ImageneBio (IMA) grant to its CFO on August 14, 2026?
ImageneBio granted its CFO 56,000 stock options and 104,000 restricted stock units on August 14, 2026. The RSUs are reflected as 65,000 and 39,000 common shares underlying RSUs, according to the reported transactions and related footnotes.
What is the exercise price and expiration date of the CFO stock options at ImageneBio (IMA)?
The CFO’s stock options cover 56,000 shares at an exercise price of $5.84 per share, expiring on August 13, 2036. These options were granted on August 14, 2026 as part of her updated employment-related equity awards.
How many restricted stock units did ImageneBio (IMA) ultimately award its CFO?
ImageneBio ultimately awarded its CFO 104,000 restricted stock units. The filing explains that, in lieu of an earlier described package of 65,000 RSUs and 95,000 options, she instead received 104,000 RSUs and 56,000 options, granted on August 14, 2026.
What is the vesting schedule for the ImageneBio (IMA) CFO’s RSUs?
The CFO’s RSUs at ImageneBio vest with 25% vesting and settling into common stock on July 20, 2027. The remaining RSUs vest in 12 equal quarterly installments thereafter, contingent on her continuous service with the company through each vesting date.
How do the ImageneBio (IMA) CFO’s stock options vest over time?
The CFO’s 56,000 options vest over four years, with 25% of the shares vesting on July 20, 2027. The remaining shares vest in 36 successive equal monthly installments, subject to her continued service with ImageneBio through each vesting date.
Did ImageneBio (IMA) change the originally described equity award structure for its CFO?
Yes. The company initially indicated the CFO would receive 65,000 RSUs and 95,000 options, but those grants were not made. Instead, she received 104,000 RSUs and 56,000 options on August 14, 2026, which are the awards reported.
AI-generated analysis. How Rhea-AI works. Not financial advice.
